1-6 of 6
Authors: Samantha Westelman
Journal Article
MDB-32. PRDM6 PROMOTES MEDULLOBLASTOMA FORMATION IN NEUROEPITHELIAL STEM CELLS AND IS A CHROMATIN REPRESSOR BY BINDING TO HISTONE H3 LYSINE 27 TRIMETHYLATION MARKS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.481
Published: 18 June 2024
Journal Article
MDB-08. MYC AND TGFΒ PROMOTE GROUP 3 MEDULLOBLASTOMA TUMOR RESISTANCE THROUGH DEREGULATION OF POLYCOMB TARGETS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.457
Published: 18 June 2024
Journal Article
MDB-09. IMPACT OF PRDM6 ON CHROMATIN ACCESSIBILITY, GENE EXPRESSION, AND MEDULLOBLASTOMA FORMATION
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i63, https://doi.org/10.1093/neuonc/noad073.242
Published: 12 June 2023
Journal Article
MDB-07. MYC AND TGFΒ PROMOTE GROUP 3 MEDULLOBLASTOMA TUMOR RESISTANCE THROUGH DEREGULATION OF KDM2B TARGETS
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i62–i63, https://doi.org/10.1093/neuonc/noad073.240
Published: 12 June 2023
Journal Article
DDDR-33. TARGETING TGFΒ PATHWAY DEPENDENCIES IN GROUP 3 MEDULLOBLASTOMA
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii106, https://doi.org/10.1093/neuonc/noac209.398
Published: 14 November 2022
Journal Article
MODL-32. IMPACT OF PRDM6 ON CHROMATIN ACCESSIBILITY, GENE EXPRESSION, AND MEDULLOBLASTOMA FORMATION
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii297–vii298, https://doi.org/10.1093/neuonc/noac209.1159
Published: 14 November 2022
